On ECHEMI
Home > Drugs > Chronic appendicitis
Chronic appendicitis
Chronic appendicitis refers to the chronic inflammatory lesions of the appendix that remain after the acute inflammation of the appendix subsides, such as hyperplasia of fibrous connective tissue in the wall, stenosis or occlusion of the lumen, twisting of the appendix, and adhesion to surrounding tissues.
  • Site of disease:

    appendix
  • Infectious :

    Not contagious
  • Frequent population:

    All groups, mostly young people
  • Related symptoms:

    Lower abdominal cramps stomach pain abdominal distension appendix ischemia and congestion bloating
  • Concurrent disease:

Related Drugs
Appendicitis anti-inflammatory tablets
Manufacturer:

Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory

Appendicitis anti-inflammatory tablets
Manufacturer:

GanSu ZhongYou Pharmaceutical Co., Ltd.

Imipenem and Cilastatin Sodium for Injection
Indication: This product is used for various infections caused by sensitive bacteria, especially for multiple bacterial complex infections and mixed infections of aerobic and anaerobic bacteria, such as peritonitis, hepatobiliary infection, intra-abdominal abscess, appendicitis, gynecological infection, lower respiratory tract infection, skin and soft tissue infection, urinary tract infection, bone and joint infection and sepsis, etc.
Manufacturer:

Han Hui Pharmaceuticals Company Limited

Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam: 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treatment of systemic and/or local bacterial infections caused by sensitive bacteria.
Manufacturer:

Shanghai SPH New ASIA Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.